InvestorsHub Logo
Followers 64
Posts 13745
Boards Moderated 0
Alias Born 01/05/2003

Re: swampboots post# 2081

Friday, 04/05/2013 1:54:49 PM

Friday, April 05, 2013 1:54:49 PM

Post# of 2096
Right, and couple others

Short airlines?

http://www.reuters.com/article/2013/04/05/us-birdflu-china-idUSBRE93201G20130405?feedType=RSS&feedName=healthNews

The virus has been shared with World Health Organization (WHO) collaborating centers in Atlanta, Beijing, London, Melbourne and Tokyo, and these groups are analyzing samples to identify the best candidate to be used for the manufacture of vaccine - if it becomes necessary.

Any decision to mass-produce vaccines against H7N9 flu will not be taken lightly, since it will mean sacrificing production of seasonal shots.

That could mean shortages of vaccine against the normal seasonal flu which, while not serious for most people, still costs thousands of lives.

Sanofi Pasteur, the world's largest flu vaccine manufacturer, said it was in continuous contact with the WHO through the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), but it was too soon to know the significance of the Chinese cases.

Other leading flu vaccine makers include GlaxoSmithKline and Novartis

Preliminary test results suggest the new flu strain responds to treatment with Roche's Tamiflu and GSK's Relenza, according to the WHO.

Fave Manhattan bar: There's No One Here. Just Poets and Artists.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.